A new study by the University of Manchester has found that a new clotbusting drug is significantly better at treating ischemic stroke than existing treatments.
L2S2 Marketing Manager Max McKiernan details the journey that led Neuro ProActive Founder, Ian Pearce, to start the development of a digital neuro rehabilitation platform.
Researchers from the Health Economics Unit and University of Leeds looked at the cost of treating strokes and found that the drugs prescribed are so effective they save the NHS money.
The cardiovascular side effects of night-time train noise is placed under the spotlight here by a group of experts from Gutenberg-University Mainz in Germany and the Danish Cancer Society.
Prof Filippo Graziani, President of the European Federation of Periodontology (EFP), turns the spotlight on periodontitis and answers if gum disease increases the risk of hypertension, heart attack and stroke.
Swarms of nanoparticles which are 15,000 times smaller than a pinhead may be able to deliver vital drugs to the brain, offering new hope to stroke patients.
Here, we find out about the role that the National Institute of Environmental Health Sciences, a publicly-funded institute, when it comes to funding obesity research in the U.S. today.
Juliet Bouverie, Chief Executive of the Stroke Association, tells us how the NHS Long Term Plan and National Stroke Programme have the potential to transform stroke services across England in the next five years.
Patients who have been diagnosed with diabetes are at a lower risk of early death if they have a doctor who they describe as showing empathy towards them, a new study from the University of Cambridge has found.
Steven A. Kautz, Professor at the Ralph H. Johnson VA Medical Center and the Medical University of South Carolina College of Health Professions gives a glimpse into the future trends for stroke recovery research.
